Drug common name | MAVATREP |
INN | mavatrep |
Description | Mavatrep (JNJ‐39439335) is a TRPV1 receptor selective competitive antagonist. It is an investigational analgesic that may be a potential treatment for pain and/or inflammation.
|
Classification | Small molecule |
Drug class | transient receptor potential antagonists; vanilloid 1 receptor antagonists |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CC(C)(O)c1ccccc1-c1ccc2[nH]c(/C=C/c3ccc(C(F)(F)F)cc3)nc2c1 |
PDB | — |
CAS-ID | 956274-94-5 |
RxCUI | — |
ChEMBL ID | CHEMBL2364618 |
ChEBI ID | — |
PubChem CID | 17751090 |
DrugBank | DB12875 |
UNII ID | F197218T99 (ChemIDplus, GSRS) |